Effect of hyperglycemia on all-cause mortality from pediatric brain injury: A systematic review and meta-analysis

Shuyun Chen1,2, Zhaohe Liu1,2

  • 1Department of Clinical Nutrition.

Medicine
|November 25, 2020
PubMed

Insights

Hyperglycemia significantly increases all-cause mortality risk in pediatric brain injury patients. Further large-scale studies are needed to confirm this association.

Area of Science:

  • Pediatric critical care medicine
  • Neurology
  • Endocrinology

Background:

  • Hyperglycemia is a common metabolic disturbance in critically ill children.
  • Brain injury in pediatric patients presents complex management challenges.
  • The impact of hyperglycemia on outcomes in pediatric brain injury remains incompletely understood.

Purpose of the Study:

  • To systematically review and meta-analyze the existing evidence on the association between hyperglycemia and all-cause mortality in pediatric patients with brain injury.

Main Methods:

  • Systematic literature search of PubMed, Embase, and Cochrane Library databases.
  • Inclusion of original observational studies assessing hyperglycemia and mortality in pediatric brain injury.
  • Meta-analysis using a fixed-effects model; risk of bias and publication bias assessment.

Main Results:

  • Nine observational studies with 970 pediatric patients (304 with hyperglycemia) were included.
  • Hyperglycemia was strongly associated with increased all-cause mortality (OR = 11.60, 95% CI 7.88-17.08).
  • No publication bias was detected, though study quality was generally low.

Conclusions:

  • Hyperglycemia is significantly linked to higher all-cause mortality in pediatric brain injury.
  • The findings highlight the critical importance of glycemic control in this vulnerable population.
  • Further robust research, including large-scale observational studies and RCTs, is warranted to confirm these results.
Abstract

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
650
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
93
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.4K
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
2.7K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.7K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.6K